Positron Emission Tomography (PET) Market - 2026-2033

October 2025 | 60 pages | ID: PD348598D6F3EN
DataM Intelligence

Abstracts

Positron Emission Tomography (PET) Marketis is growing with a CAGR of 5.40% during the forecast period 2026-2035.

The Positron Emission Tomography (PET) Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Positron Emission Tomography (PET) Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type

• Segment Growth Trends
• Hybrid PET Systems*
• Digital PET Systems
• PET Scanners
• Others

By Application

• Segment Growth Trends
• Oncology*
• Neurology
• Cardiology
• Infectious Diseases
• Others

By End-User

• Segment Growth Trends
• Hospitals*
• Specialty Clinics
• Diagnostic Imaging Centers
• Ambulatory Surgical Centers
• Academic & Research Institutes

Regional Analysis for Positron Emission Tomography (PET) Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Positron Emission Tomography (PET) Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Application
2.5. Snippet by End-User
2.6. Snippet by Region

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Rapid Adoption of Digital and Hybrid PET Systems
    3.1.1.2. Regulatory Approvals and Expanding Reimbursement Policies
  3.1.2. Restraints
    3.1.2.1. High Capital and Operational Costs
    3.1.2.2. Competition from Alternative Imaging Modalities
  3.1.3. Opportunity
    3.1.3.1. Expansion of Digital and Total-Body PET Systems
    3.1.3.2. Theranostics and Personalized Medicine
  3.1.4. Impact Analysis

4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

4.1. Market Leaders and Pioneers
  4.1.1. Emerging Pioneers and Prominent Players
  4.1.2. Established Leaders with the Largest Marketing Brand
  4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
  4.3.1. North America
  4.3.2. Europe
  4.3.3. Asia Pacific
  4.3.4. South America
  4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
  4.4.1. Threat of New Entrants
  4.4.2. Threat of Substitutes
  4.4.3. Bargaining Power of Suppliers
  4.4.4. Bargaining Power of Buyers
  4.4.5. Intensity of Competitive Rivalry
4.5. Supply Chain Analysis
  4.5.1. Raw material Suppliers
  4.5.2. Manufacturers
  4.5.3. Regulatory Approvals/Certifications
  4.5.4. Distributors
  4.5.5. End-Users
4.6. Patent Analysis
4.7. Unmet Needs and Gaps
4.8. Recommended Strategies for Market Entry and Expansion
4.9. Pricing Analysis and Price Dynamics

5. POSITRON-EMISSION TOMOGRAPHY (PET) MARKET, BY PRODUCT TYPE

5.1. Introduction
  5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  5.1.2. Market Attractiveness Index, By Product Type
  5.1.3. Segment Growth Trends
5.2. Hybrid PET Systems*
  5.2.1. Introduction
  5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Digital PET Systems
5.4. PET Scanners
5.5. Others

6. POSITRON-EMISSION TOMOGRAPHY (PET) MARKET, BY APPLICATION

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  6.1.2. Market Attractiveness Index, By Application
  6.1.3. Segment Growth Trends
6.2. Oncology*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Neurology
6.4. Cardiology
6.5. Infectious Diseases
6.6. Others

7. POSITRON-EMISSION TOMOGRAPHY (PET) MARKET, BY END-USER

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  7.1.2. Market Attractiveness Index, By End-User
  7.1.3. Segment Growth Trends
7.2. Hospitals*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Specialty Clinics
7.4. Diagnostic Imaging Centers
7.5. Ambulatory Surgical Centers
7.6. Academic & Research Institutes

8. POSITRON-EMISSION TOMOGRAPHY (PET) MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  8.1.2. Market Attractiveness Index, By Region
  8.1.3. Regional Growth Trends
8.2. North America
  8.2.1. Introduction
  8.2.2. Key Region-Specific Dynamics
  8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    8.2.3.1. Hybrid PET Systems
    8.2.3.2. Digital PET Systems
    8.2.3.3. PET Scanners
    8.2.3.4. Others
  8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    8.2.4.1. Oncology
    8.2.4.2. Neurology
    8.2.4.3. Cardiology
    8.2.4.4. Infectious Diseases
    8.2.4.5. Others
  8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    8.2.5.1. Hospitals
    8.2.5.2. Specialty Clinics
    8.2.5.3. Diagnostic Imaging Centers
    8.2.5.4. Ambulatory Surgical Centers
    8.2.5.5. Academic & Research Institutes
  8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    8.2.6.1. U.S.
    8.2.6.2. Canada
    8.2.6.3. Mexico
  8.2.7. Europe
    8.2.7.1. Introduction
    8.2.7.2. Key Region-Specific Dynamics
    8.2.7.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      8.2.7.3.1. Hybrid PET Systems
      8.2.7.3.2. Digital PET Systems
      8.2.7.3.3. PET Scanners
      8.2.7.3.4. Others
    8.2.7.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      8.2.7.4.1. Oncology
      8.2.7.4.2. Neurology
      8.2.7.4.3. Cardiology
      8.2.7.4.4. Infectious Diseases
      8.2.7.4.5. Others
    8.2.7.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
      8.2.7.5.1. Hospitals
      8.2.7.5.2. Specialty Clinics
      8.2.7.5.3. Diagnostic Imaging Centers
      8.2.7.5.4. Ambulatory Surgical Centers
      8.2.7.5.5. Academic & Research Institutes
    8.2.7.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      8.2.7.6.1. Germany
      8.2.7.6.2. UK
      8.2.7.6.3. France
      8.2.7.6.4. Spain
      8.2.7.6.5. Italy
      8.2.7.6.6. Rest of Europe
  8.2.8. Asia-Pacific
    8.2.8.1. Introduction
    8.2.8.2. Key Region-Specific Dynamics
    8.2.8.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      8.2.8.3.1. Hybrid PET Systems
      8.2.8.3.2. Digital PET Systems
      8.2.8.3.3. PET Scanners
      8.2.8.3.4. Others
    8.2.8.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      8.2.8.4.1. Oncology
      8.2.8.4.2. Neurology
      8.2.8.4.3. Cardiology
      8.2.8.4.4. Infectious Diseases
      8.2.8.4.5. Others
    8.2.8.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
      8.2.8.5.1. Hospitals
      8.2.8.5.2. Specialty Clinics
      8.2.8.5.3. Diagnostic Imaging Centers
      8.2.8.5.4. Ambulatory Surgical Centers
      8.2.8.5.5. Academic & Research Institutes
    8.2.8.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      8.2.8.6.1. China
      8.2.8.6.2. India
      8.2.8.6.3. Japan
      8.2.8.6.4. South Korea
      8.2.8.6.5. Rest of Asia-Pacific
  8.2.9. South America
    8.2.9.1. Introduction
    8.2.9.2. Key Region-Specific Dynamics
    8.2.9.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      8.2.9.3.1. Hybrid PET Systems
      8.2.9.3.2. Digital PET Systems
      8.2.9.3.3. PET Scanners
      8.2.9.3.4. Others
    8.2.9.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      8.2.9.4.1. Oncology
      8.2.9.4.2. Neurology
      8.2.9.4.3. Cardiology
      8.2.9.4.4. Infectious Diseases
      8.2.9.4.5. Others
    8.2.9.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
      8.2.9.5.1. Hospitals
      8.2.9.5.2. Specialty Clinics
      8.2.9.5.3. Diagnostic Imaging Centers
      8.2.9.5.4. Ambulatory Surgical Centers
      8.2.9.5.5. Academic & Research Institutes
    8.2.9.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      8.2.9.6.1. Brazil
      8.2.9.6.2. Argentina
      8.2.9.6.3. Rest of South America
  8.2.10. Middle East and Africa
    8.2.10.1. Introduction
    8.2.10.2. Key Region-Specific Dynamics
    8.2.10.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
      8.2.10.3.1. Hybrid PET Systems
      8.2.10.3.2. Digital PET Systems
      8.2.10.3.3. PET Scanners
      8.2.10.3.4. Others
    8.2.10.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
      8.2.10.4.1. Oncology
      8.2.10.4.2. Neurology
      8.2.10.4.3. Cardiology
      8.2.10.4.4. Infectious Diseases
      8.2.10.4.5. Others
    8.2.10.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
      8.2.10.5.1. Hospitals
      8.2.10.5.2. Specialty Clinics
      8.2.10.5.3. Diagnostic Imaging Centers
      8.2.10.5.4. Ambulatory Surgical Centers
      8.2.10.5.5. Academic & Research Institutes

9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. FDA Approvals
9.5. Key Developments in Product Portfolios and Innovations
9.6. Company Benchmarking

10. COMPANY PROFILES

10.1. GE HealthCare*
  10.1.1. Company Overview
  10.1.2. Product Portfolio
    10.1.2.1. Product Description
    10.1.2.2. Product Key Performance Indicators (KPIs)
  10.1.3. Financial Overview
    10.1.3.1. Company Revenue
    10.1.3.2. Geographical Revenue Shares
    10.1.3.3. Revenue Forecasts
  10.1.4. Key Developments
    10.1.4.1. Mergers & Acquisitions
    10.1.4.2. Key Product Development Activities
    10.1.4.3. Regulatory Approvals, etc.
    10.1.4.4. SWOT Analysis
10.2. Siemens Healthineers
10.3. CANON MEDICAL SYSTEMS CORPORATION
10.4. Koninklijke Philips N.V.
10.5. United Imaging Healthcare Co., Ltd.
10.6. Neusoft Medical Systems Co., Ltd.
10.7. Shimadzu Corporation
10.8. Bruker
10.9. Mediso Ltd.
10.10. Positrigo AG (LIST NOT EXHAUSTIVE )

11. ASSUMPTIONS AND RESEARCH METHODOLOGY

11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation

12. APPENDIX

12.1. About Us and Services
12.2. Contact Us